COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 3052: Articles 30511-30520  | Next

Early Phylogenetic Estimate Of The Effective Reproduction Number Of 2019-nCoV
Lai, A., Bergna, A., Acciarri, C., Galli, M., Zehender, G.
10.1101/2020.02.19.20024851 — Posted: 2020-02-23
Clinical characteristics of 50404 patients with 2019-nCoV infection
Sun, P., Qie, S., Liu, Z., Ren, J., Jianing Xi, J.
10.1101/2020.02.18.20024539 — Posted: 2020-02-23 Discussion: Onsite
Novel Coronavirus 2019 (Covid-19) epidemic scale estimation: topological network-based infection dynamic model
Tang, K., Huang, Y., Chen, M.
10.1101/2020.02.20.20023572 — Posted: 2020-02-23
Trends and prediction in daily incidence of novel coronavirus infection in China, Hubei Province and Wuhan City: an application of Farr law
Xu, J., Cheng, Y., Yuan, X., Li, W. V., Zhang, L.
10.1101/2020.02.19.20025148 — Posted: 2020-02-23
Phase adjusted estimation of the number of 2019 novel coronavirus cases in Wuhan, China
Wang, H., Wang, Z., Dong, Y., Chang, R., Xu, C., Yu, X., Zhang, S., Tsamlag, L., Shang, M., Huang, J., Wang, Y., Xu, G., Shen, T., Zhang, X., Cai, Y.
10.1101/2020.02.18.20024281 — Posted: 2020-02-23
Clinical Characteristics of 24 Asymptomatic Infections with COVID-19 Screened among Close Contacts in Nanjing, China
Hu, Z., Song, C., Xu, C., Jin, G., Chen, Y., Xu, X., Ma, H., Chen, W., Lin, Y., Zheng, Y., Wang, J., hu, z., Yi, Y., Shen, H.
10.1101/2020.02.20.20025619 — Posted: 2020-02-23 Discussion: Onsite
Breadth of concomitant immune responses underpinning viral clearance and patient recovery in a non-severe case of COVID-19
Thevarajan, I., Nguyen, T. H., Koutsakos, M., Druce, J., Caly, L., van de Sandt, C. E., Jia, X., Nicholson, S., Catton, M., Cowie, B., Tong, S., Lewin, S., Kedzierska, K.
10.1101/2020.02.20.20025841 — Posted: 2020-02-23 Discussion: Onsite
SARS-CoV-2 infection does not significantly cause acute renal injury: an analysis of 116 hospitalized patients with COVID-19 in a single hospital, Wuhan, China
Wang, L., Li, X., Chen, H., Yan, S., Li, Y., Li, D., Gong, Z.
10.1101/2020.02.19.20025288 — Posted: 2020-02-23 Discussion: Onsite
The cross-sectional study of hospitalized coronavirus disease 2019 patients in Xiangyang, Hubei province
Ai, J., Chen, J., Wang, Y., Liu, X., Fan, W., Qu, G., Zhang, M., Pei, S. P., Tang, B., Yuan, S., Li, Y., Wang, L., Huang, G., Pei, B.
10.1101/2020.02.19.20025023 — Posted: 2020-02-23
Early Prediction of Disease Progression in 2019 Novel Coronavirus Pneumonia Patients Outside Wuhan with CT and Clinical Characteristics
Feng, Z., Yu, Q., Yao, S., Luo, L., Duan, J., Yan, Z., Yang, M., Tan, H., Ma, M., Li, T., Yi, D., Mi, Z., Zhao, H., Jiang, Y., He, Z., Li, H., Nie, W., Liu, Y., Zhao, J., Luo, M., Liu, X., Rong, P., Wang, W.
10.1101/2020.02.19.20025296 — Posted: 2020-02-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).